Patents by Inventor Ingrid Fellows

Ingrid Fellows has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted heterocycles and methods of use
    Patent number: 7652009
    Abstract: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
    Type: Grant
    Filed: November 29, 2005
    Date of Patent: January 26, 2010
    Assignee: Amgem Inc.
    Inventors: Tae-Seong Kim, Steven Bellon, Shon Booker, Noel D'Angelo, Celia Dominguez, Ingrid Fellows, Matthew Lee, Longbin Liu, Elizabeth Rainbeau, Aaron C. Siegmund, Andrew Tasker, Ning Xi, Yuan Cheng
  • Methods for preparation and use of psorospermin analogs
    Patent number: 7244760
    Abstract: Psorospermin is a cytotoxic dihydroflranoxanthone that has found to exhibit significant activity against various tumor cell lines. Unfortunately, psorospermin is no longer readily available from its natural plant source. The present invention is directed to a method for preparing psorospermin and psorospermin analogs. Methods are also disclosed for utilizing psorospermin analogs to inhibit cellular proliferation.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: July 17, 2007
    Assignees: Board of Regents, The University of Texas System, Cylene Pharmaceuticals, Inc.
    Inventors: Laurence Hurley, Ingrid Fellows, Michael Kenric Schwaebe, Jeffrey Paul Whitten
  • Bis-aryl kinase inhibitors and method
    Publication number: 20070054903
    Abstract: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
    Type: Application
    Filed: June 30, 2006
    Publication date: March 8, 2007
    Applicant: Amgen Inc.
    Inventors: Tae-Seong Kim, Jean-Christophe Harmange, Steven Bellon, Shon Booker, Noel D'Angelo, Celia Dominguez, Ingrid Fellows, Julie Germain, Timothy Harvey, Joseph Kim, Matthew Lee, Longbin Liu, Vinod Patel, Andrew Tasker
  • Substituted heterocycles and methods of use
    Publication number: 20060252777
    Abstract: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
    Type: Application
    Filed: November 29, 2005
    Publication date: November 9, 2006
    Applicant: AMGEN INC.
    Inventors: Tae-Seong Kim, Steven Bellon, Shon Booker, Noel D'Angelo, Celia Dominguez, Ingrid Fellows, Matthew Lee, Longbin Liu, Elizabeth Rainbeau, Aaron Siegmund, Andrew Tasker, Ning Xi, Yuan Cheng
  • Methods for preparation and use of psorospermin analogs
    Publication number: 20060084698
    Abstract: Psorospermin is a cytotoxic dihydrofuranoxanthone that has found to exhibit significant activity against various tumor cell lines. Unfortunately, psorospermin is no longer readily available from its natural plant source. The present invention is directed to a method for preparing psorospermin and psorospermin analogs. Methods are also disclosed for utilizing psorospermin analogs to inhibit cellular proliferation.
    Type: Application
    Filed: September 26, 2005
    Publication date: April 20, 2006
    Inventors: Laurence Hurley, Ingrid Fellows, Michael Schwaebe, Jeffrey Whitten
  • Methods for preparation and use of psorospermin analogs
    Publication number: 20030120093
    Abstract: Psorospermin is a cytotoxic dihydroflranoxanthone that has found to exhibit significant activity against various tumor cell lines. Unfortunately, psorospermin is no longer readily available from its natural plant source. The present invention is directed to a method for preparing psorospermin and psorospermin analogs. Methods are also disclosed for utilizing psorospermin analogs to inhibit cellular proliferation.
    Type: Application
    Filed: May 20, 2002
    Publication date: June 26, 2003
    Inventors: Laurence Hurley, Ingrid Fellows, Michael Kenric Schwaebe, Jeffrey Paul Whitten